Management of multiple sclerosis (MS) may comprise clinical interventions and self-management strategies, including complementary therapies and modifiable lifestyle factors such as exercise and smoking cessation. Lifestyle modifications and complementary therapies with proven safety and efficacy are essential as part of best-practice MS management, especially when faced with limited access to healthcare services. However, it is unclear to what extent MS clinical practice guidelines and consensus statements address these strategies. A systematic review was conducted, wherein MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus, Web of Science, guideline databases and developer sites were searched for guidelines and consensus statements that addressed l...
OBJECTIVES: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
<div><p>Background</p><p>High quality clinical practice guidelines (CPGs) can provide clinicians wit...
Objectives: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
ABSTRACTMultiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nerv...
Trabulsi, Jillian C.Background: Conventional treatments for multiple sclerosis (MS) are often ineff...
Objective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central ne...
Multiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nervous syst...
Background: Complementary and alternative med- icine (CAM) use in individuals with multiple sclerosi...
plementary and alternative medicine as a group of diverse medical and health care systems, practices...
People with multiple sclerosis (PwMS) commonly use complementary and alternative medicines (CAM), bu...
From PubMed via Jisc Publications Router.Publication status: aheadofprintRemaining physically active...
Background: No intervention has proven effective in modifying long-term disease prognosis in Multipl...
Objectives: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
High-quality clinical practice guidelines (CPGs) can provide evidence-based recommendations for opti...
This article identifies payment policy perspectives of the American Academy of Neurology’s guideline...
OBJECTIVES: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
<div><p>Background</p><p>High quality clinical practice guidelines (CPGs) can provide clinicians wit...
Objectives: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
ABSTRACTMultiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nerv...
Trabulsi, Jillian C.Background: Conventional treatments for multiple sclerosis (MS) are often ineff...
Objective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central ne...
Multiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nervous syst...
Background: Complementary and alternative med- icine (CAM) use in individuals with multiple sclerosi...
plementary and alternative medicine as a group of diverse medical and health care systems, practices...
People with multiple sclerosis (PwMS) commonly use complementary and alternative medicines (CAM), bu...
From PubMed via Jisc Publications Router.Publication status: aheadofprintRemaining physically active...
Background: No intervention has proven effective in modifying long-term disease prognosis in Multipl...
Objectives: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
High-quality clinical practice guidelines (CPGs) can provide evidence-based recommendations for opti...
This article identifies payment policy perspectives of the American Academy of Neurology’s guideline...
OBJECTIVES: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...
<div><p>Background</p><p>High quality clinical practice guidelines (CPGs) can provide clinicians wit...
Objectives: To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or ...